DANCANN PHARMA
Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.
DANCANN PHARMA
Industry:
Biotechnology Manufacturing Medical Pharmaceutical Therapeutics
Founded:
2018-01-01
Address:
Ansager, Syddanmark, Denmark
Country:
Denmark
Website Url:
http://www.dancann.com
Status:
Active
Contact:
45 6916 0393
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Euro Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS YouTube
Current Employees Featured
Key Employee Changes
Official Site Inspections
http://www.dancann.com Semrush global rank: 9.28 M Semrush visits lastest month: 182
- Host name: 76.76.21.21
- IP address: 76.76.21.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago

More informations about "Dancann Pharma"
About - dancann.com
At DanCann Pharma, Peter Søndergaard will lead the finance function in the growing organization, which consists of DanCann Pharma A/S and the subsidiary CannGros ApS.See details»
Home [www.dancann.com]
The term for formulated, processed or synthetic cannabis sold as a finished product which has undergone full medical trials, and holds a medical marketing authorization.See details»
Investor Relations - dancann.com
DanCann Pharma is focused on discovering, developing, manufacturing, and commercializing of novel cannabinoid therapeutics in a broad range of disease areas. DanCann Pharma was โฆSee details»
DanCann Pharma A/S: A strong and growing organization is ready โฆ
DanCann Pharma A/S: A strong and growing organization is ready to fulfill the commercial ambitions COPENHAGEN, Denmark, November 10, 2022 - DanCann Pharma A/S (SS: โฆSee details»
Dancann Pharma - Crunchbase Company Profile & Funding
Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.See details»
DanCann Pharma Company Description - Stock Analysis
Nov 28, 2024 Company profile for DanCann Pharma A/S (NGM: DANCAN) with a description, list of executives, contact details and other key facts.See details»
Dancann Pharma - Funding, Financials, Valuation & Investors
Dancann Pharma manufactures medical cannabis and develops novel cannabinoid therapeutics for a broad range of diseases.See details»
DanCann Pharma DanCann Pharma's CEO: Building organization โฆ
May 6, 2022 DanCann Pharma was founded in 2018 and has since taken huge strides towards establishing itself as a manufacturer and distributor of products in the medical cannabis โฆSee details»
DanCann Pharma: DanCann Pharma A/S - MarketScreener
6 days ago DanCann Pharma is represented through its membership in the Medicinsk Cannabis Industri (MCI), where the Company's CEO, Jeppe Krog Rasmussen, serves as Vice Chairman โฆSee details»
DanCann Pharma A/S (DANCAN.ST) - Yahoo Finance Canada
Find the latest DanCann Pharma A/S (DANCAN.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
DanCann Pharma A/S: A strong and growing organization is ready โฆ
Nov 10, 2022 COPENHAGEN, Denmark, November 10, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by โฆSee details»
DanCann Pharma A/S: A strengthened market position after an โฆ
DanCann Pharma is looking into a new reality, now that both capital increase, EU-GMP certification and share listing in the USA have been ticked off. The DanCann Pharma CEO is โฆSee details»
DanCann Pharma A/S: Agreement Reached on Permanent โฆ
6 days ago To ensure continued collaboration and knowledge sharing, the reference group for medicinal cannabis will be extended through 2025 and 2026. DanCann Pharma is represented โฆSee details»
DanCann Pharma A/S: A strong and growing organization is ready โฆ
Nov 10, 2022 COPENHAGEN, Denmark, November 10, 2022 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the โCompanyโ), a Danish company powered by โฆSee details»
DanCann Pharma A/S strengthening the organization with new โฆ
DanCann Pharma is a vertically integrated, licensed production and distribution Company. The Company focuses on discovering, developing, manufacturing, and commercializing new โฆSee details»
Investor Relations - dancann.com
At DanCann Pharma, Peter Søndergaard will lead the finance function in the growing organization, which consists of DanCann Pharma A/S and the subsidiary CannGros ApS.See details»
DanCann Pharma's CEO: Building organization and strong results โฆ
May 6, 2022 DanCann Pharma was founded in 2018 and has since taken huge strides towards establishing itself as a manufacturer and distributor of products in the medical cannabis โฆSee details»
Patient - dancann.com
Pharmaceutical Cannabis The term for formulated, processed or synthetic cannabis sold as a finished product which has undergone full medical trials, and holds a medical marketing โฆSee details»
Medical Cannabis - dancann.com
Pharmaceutical cannabis means the term for formulated, processed or synthetic cannabis sold as a finished product, which has undergone full medical trials, and holds (in one or more โฆSee details»
Investor Relations - dancann.com
Introduction Share Information Press Releases Initial Public Offering (IPO) General Meetings Corporate Governance Financial Calendar Financial Reports IR-Contact Board of Directors โฆSee details»